MBVX MabVax Therapeutics Holdings, Inc. $MBVX Company

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
MBVX MabVax Therapeutics Holdings, Inc. $MBVX Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=MBVX&...mp;yt0=Go!

Last Updated: 12/24/2016 20:21:52

Current Price and Quotes
Last Price 3.46
Previous Close 3.40 Open 3.44
Daily Range 3.42 - 3.53 52wk Range 3.10 - 6.05
Volume 8,158 Dividend N/A
Average Vol (30d) 71,826 Net Dividend Yield N/A




Financials
Period Ending Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012
Total Revenue 1,267 314 366 -
Cost of Revenue - - - -
Gross Profit 1,267 314 366 -
Operating Expenses

Research and Development 9,597 3,503 2,967 3,524
Sales, General and Admin. 9,795 5,204 1,442 4,455
Non-Recurring Items - - - -
Other - - - -
Operating Income (18,125) (8,393) (4,043) (7,979)
Income From Continuing Operations

Add'l Income/Expense Items 20 475 - 8
Earnings Before Interest and Tax (18,105) (7,918) (4,045) (7,971)
Interest Expense - - - -
Earnings Before Tax (18,105) (7,918) (4,045) (7,971)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (18,105) (7,918) (4,045) (7,971)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (18,105) (7,918) (4,045) (7,971)
Preferred Stock and Other Adjustments (17,946) (2,660) (692) -
Net Income Applicable to Common Shareholders (36,051) (10,578) (4,737) (7,971)

Recent News
Source
Dec 5, 2016 MabVax Therapeutics Expands Phase I Clinical Trial Investigation for Patients with Pancreatic Cancer to Include HonorHealth Research Institute PR NEWSWIRE
Nov 29, 2016 MabVax Therapeutics to Present at the 9th Annual LD Micro Main Event ACCESSWIRE
Nov 28, 2016 MabVax Therapeutics Enrolls First Patients in Expansion of Phase I Clinical Trial Treating Newly Diagnosed Pancreatic Cancer Patients PR NEWSWIRE
Nov 28, 2016 Enrollment underway in expansion phase of early-stage study of MabVax's MVT-5873 in pancreatic cancer; shares up 3% premarket Seeking Alpha
Nov 16, 2016 MabVax Therapeutics: Opportunity In Unmet Cancer Need Seeking Alpha
Nov 14, 2016 MabVax Therapeutics to Hold Conference Call to Provide Corporate Update On Monday, November 14, 2016 PR NEWSWIRE
Nov 14, 2016 MabVax Therapeutics Reports Interim Safety and Imaging Results from Phase I Clinical Trials in HuMab-5B1 Antibody Development Programs PR NEWSWIRE
Nov 10, 2016 MabVax Therapeutics Reports Third Quarter 2016 Financial Results and Schedules Conference Call to Provide Corporate Update On Monday, November 14, 2016 PR NEWSWIRE
Nov 7, 2016 MabVax Therapeutics Receives U.S. Patent for its Clinical Stage HuMab-5B1 Antibody PR NEWSWIRE
Oct 13, 2016 MabVax Therapeutics to Present at the BIO Investor Forum PR NEWSWIRE

1
2
next >

MBVX MabVax Therapeutics Holdings, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=MBVX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/MBVX/quote
Stock Chart http://www.otcmarkets.com/stock/MBVX/chart
Company Info http://www.otcmarkets.com/stock/MBVX/company-info
Recent News http://www.otcmarkets.com/stock/MBVX/news
Financials http://www.otcmarkets.com/stock/MBVX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/MBVX/filings
Short Sales http://www.otcmarkets.com/stock/MBVX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/MBVX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/MBVX/research
Summary http://finance.yahoo.com/q?s=MBVX
Historical Prices http://finance.yahoo.com/q/hp?s=MBVX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=MBVX
Basic Chart http://finance.yahoo.com/q/bc?s=MBVX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=MBVX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=MBVX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=MBVX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=MBVX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=MBVX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=MBVX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=MBVX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=MBVX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=MBVX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=MBVX
Balance Sheet http://finance.yahoo.com/q/bs?s=MBVX
Cash Flow http://finance.yahoo.com/q/cf?s=MBVX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/MBVX
Market Watch http://www.marketwatch.com/investing/stock/MBVX
Bloomberg http://www.bloomberg.com/quote/MBVX:US
Morningstar http://quotes.morningstar.com/stock/s?t=MBVX
Bussinessweek http://investing.businessweek.com/research/st...icker=MBVX
Barchart http://www.barchart.com/quotes/stocks/MBVX
OTC Short Report http://otcshortreport.com/index.php?index=MBVX
Investopedia http://www.investopedia.com/markets/stocks/MBVX/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 3

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 11

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 5

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 4

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 4

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading

Top 5 Most Recently Viewed Articles

Futu Holdings Achieves Remarkable Financial Success in 2024

Updated Category News Views 315

Futu Holdings Reports Impressive Financial Growth Moomoo's parent company Futu Holdings Ltd. (NASDAQ: FUTU), a prominent tech-driven online brokerage, announced its unaudited financial results for the fourth quarter of 2024. The Company achieved an impressive revenue of US$570.6 million, marking an 86.8% increase from the previous year. Additionally, the non-GAAP adjusted...

Continue Reading
Sapiens and Addresscloud Team Up to Boost Insurance Risk Insights

Updated Category News Views 36

Sapiens Partners with Addresscloud to Improve Risk Insights This collaboration empowers insurers to enhance their risk evaluation and make better underwriting decisions. Sapiens International Corporation (NASDAQ: SPNS), a leading provider of software solutions for the insurance sector, has teamed up with Addresscloud, a provider of cloud-based location intelligence. This...

Continue Reading
Class Action Lawsuit Alert for Viatris Inc. Shareholders

Updated Category News Views 136

Important Notice for Viatris Inc. Investors Levi & Korsinsky, LLP is reaching out to investors of Viatris Inc., also known as Viatris or the Company, recognized by the ticker NASDAQ: VTRS. This notification serves as a preliminary alert regarding a class action securities lawsuit targeting the interests of affected investors. Class Definition and Purpose of the Lawsuit...

Continue Reading
Dynacor Group Announces Upcoming Dividend in September 2025

Updated Category News Views 121

Dynacor Group's Dividend Declaration Dynacor Group Inc. (TSX: DNG) has announced its intention to provide a monthly dividend payment for September 2025. This payment is set at C$0.01333 for each common share and is scheduled to be distributed on September 18, 2025, to those shareholders identified as of September 11, 2025. This marks the 66th overall dividend and the 56th...

Continue Reading
Equitable Bank Lowers Lending Rate for Increased Accessibility

Updated Category News Views 179

Equitable Bank Announces Prime Rate Reduction Equitable Bank, known as Canada’s Challenger Bank™, has taken a proactive step in promoting financial accessibility by announcing a reduction in its prime lending rate. This new rate is set to decrease by 50 basis points, bringing it down from 5.95% to a more attractive 5.45%. Impact on Borrowers This adjustment is...

Continue Reading